BG64707B1 - 2-хало-6-о-заместени кетолидни производни - Google Patents

2-хало-6-о-заместени кетолидни производни Download PDF

Info

Publication number
BG64707B1
BG64707B1 BG104434A BG10443400A BG64707B1 BG 64707 B1 BG64707 B1 BG 64707B1 BG 104434 A BG104434 A BG 104434A BG 10443400 A BG10443400 A BG 10443400A BG 64707 B1 BG64707 B1 BG 64707B1
Authority
BG
Bulgaria
Prior art keywords
compound
formula
quinolinyl
xef
hydrogen
Prior art date
Application number
BG104434A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG104434A (en
Inventor
Ly Phan
Yat Sun Or
Daniel Chu
Jacob Plattner
Yan Chen
Richard Clark
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of BG104434A publication Critical patent/BG104434A/xx
Publication of BG64707B1 publication Critical patent/BG64707B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
BG104434A 1997-10-29 2000-05-15 2-хало-6-о-заместени кетолидни производни BG64707B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95988197A 1997-10-29 1997-10-29
US15423998A 1998-09-16 1998-09-16

Publications (2)

Publication Number Publication Date
BG104434A BG104434A (en) 2001-01-31
BG64707B1 true BG64707B1 (bg) 2005-12-30

Family

ID=26851273

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104434A BG64707B1 (bg) 1997-10-29 2000-05-15 2-хало-6-о-заместени кетолидни производни

Country Status (24)

Country Link
EP (1) EP1027362B1 (fr)
JP (1) JP2001521039A (fr)
KR (1) KR100536420B1 (fr)
CN (1) CN1240707C (fr)
AR (1) AR015994A1 (fr)
AT (1) ATE298760T1 (fr)
AU (1) AU751448B2 (fr)
BG (1) BG64707B1 (fr)
BR (1) BR9813319A (fr)
CA (1) CA2307788C (fr)
CO (1) CO4990960A1 (fr)
CZ (1) CZ300063B6 (fr)
DE (1) DE69830739T2 (fr)
DK (1) DK1027362T3 (fr)
ES (1) ES2244094T3 (fr)
HU (1) HUP0004282A3 (fr)
IL (1) IL135519A0 (fr)
NO (1) NO20002190L (fr)
NZ (1) NZ503822A (fr)
PL (1) PL191453B1 (fr)
PT (1) PT1027362E (fr)
SK (1) SK286397B6 (fr)
TR (1) TR200001142T2 (fr)
WO (1) WO1999021871A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39743E1 (en) * 1998-10-15 2007-07-24 Aventis Pharma S.A. 2-halogenated derivatives of 5-0 desosaminyl-erythronolide a, their preparation process and their antibiotic use
FR2784682B1 (fr) * 1998-10-15 2002-12-06 Hoechst Marion Roussel Inc Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6395710B1 (en) 1999-04-16 2002-05-28 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6569836B2 (en) 1999-12-02 2003-05-27 Abbott Laboratories 6-O-alkyl-2-nor-2-substituted ketolide derivatives
DE60039122D1 (de) * 1999-12-02 2008-07-17 Abbott Lab 6-o-alkyl-2-nor-2-substituierte ketolidderivate
JP2001261694A (ja) * 2000-03-06 2001-09-26 Pfizer Prod Inc ケトライド抗生物質
US6605707B1 (en) * 2000-03-23 2003-08-12 Abbott Laboratories Process for the preparation of 6-O-propargyl erythromycin derivatives
TR200401847T4 (tr) 2000-06-30 2004-09-21 Pfizer Products Inc. Makrolit antibiyotikler.
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
CN1589277A (zh) 2001-09-17 2005-03-02 奥索-麦克尼尔药品公司 6-o-氨基甲酸酯-11,12-内酯-酮内酯抗菌剂
AU2002346475A1 (en) 2001-12-05 2003-06-23 Ortho-Mcneil Pharmaceutical, Inc. 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
MXPA04007883A (es) * 2002-02-13 2004-11-26 Abbott Lab Compuestos antimicrobianos de macrolido.
WO2003090761A1 (fr) * 2002-04-25 2003-11-06 Abbott Laboratories Antibacteriens 9-oxime macrolide
WO2003090760A1 (fr) * 2002-04-25 2003-11-06 Abbott Laboratories Composes antibacteriens a base d'oxolide
WO2004078771A1 (fr) * 2003-03-07 2004-09-16 Taisho Pharmaceutical Co., Ltd. Derive de ketolide 2-fluoro-6-o-substitue
JP2007254285A (ja) * 2004-03-16 2007-10-04 Taisho Pharmaceut Co Ltd 2−フルオロ−6−o−置換ケトライド誘導体
RU2011153353A (ru) * 2009-05-27 2013-07-10 Вокхардт Рисерч Сентер Кетолидные соединения, обладающие противомикробной активностью

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8506380D0 (en) * 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5631355A (en) * 1992-04-22 1997-05-20 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide a derivatives
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
CZ300063B6 (cs) 2009-01-21
CA2307788C (fr) 2008-05-20
ATE298760T1 (de) 2005-07-15
CA2307788A1 (fr) 1999-05-06
EP1027362A1 (fr) 2000-08-16
ES2244094T3 (es) 2005-12-01
AU1288199A (en) 1999-05-17
PL340290A1 (en) 2001-01-29
CZ20001525A3 (cs) 2000-10-11
BG104434A (en) 2001-01-31
CN1240707C (zh) 2006-02-08
IL135519A0 (en) 2001-05-20
DK1027362T3 (da) 2005-10-31
KR100536420B1 (ko) 2005-12-16
HUP0004282A3 (en) 2001-10-29
NO20002190D0 (no) 2000-04-27
KR20010015793A (ko) 2001-02-26
HK1031383A1 (en) 2001-06-15
CN1283199A (zh) 2001-02-07
DE69830739T2 (de) 2006-04-20
BR9813319A (pt) 2000-08-22
HUP0004282A2 (hu) 2001-04-28
WO1999021871A1 (fr) 1999-05-06
EP1027362B1 (fr) 2005-06-29
PL191453B1 (pl) 2006-05-31
TR200001142T2 (tr) 2000-09-21
AR015994A1 (es) 2001-05-30
SK6332000A3 (en) 2000-09-12
NO20002190L (no) 2000-06-29
AU751448B2 (en) 2002-08-15
DE69830739D1 (de) 2005-08-04
JP2001521039A (ja) 2001-11-06
NZ503822A (en) 2002-12-20
CO4990960A1 (es) 2000-12-26
SK286397B6 (sk) 2008-09-05
PT1027362E (pt) 2005-08-31

Similar Documents

Publication Publication Date Title
US6124269A (en) 2-Halo-6-O-substituted ketolide derivatives
EP1027362B1 (fr) 2-halo ketolides avec substitution -6-o
EP1015467B1 (fr) Derives d'erythromycine pontes en 6,9
EP1025114B1 (fr) Derives d'erythromycine cetolides, modifies en n-3' et substitues en o-6, possedant une activite antibacterienne
SK13162001A3 (sk) 6-o-substituované makrolidy majúce antibakteriálnu aktivitu
AU1286799A (en) 6,11-bridged erythromycin derivatives
US6034069A (en) 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
EP1181300B1 (fr) Derives ketolide de 6-o-carbamate
US6569836B2 (en) 6-O-alkyl-2-nor-2-substituted ketolide derivatives
US5780604A (en) 11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides
EP1233971B1 (fr) Derives 6-o-alkyl-2-nor-2- substitues de ketolides
HK1031383B (en) 2-halo-6-o-subsituted ketolide derivatives
WO2001063539A2 (fr) Agents anti-infectieux utiles contre des souches de bacteries resistant a l'action de plusieurs medicaments
MXPA00004226A (es) Derivados de ketólido 2-halo-6-o-substituidos
MXPA00003117A (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
CZ2000811A3 (cs) 6,9-můstkové erythromycinové deriváty a způsob jejich přípravy
CZ20001045A3 (cs) 3-N-módilikováné 6-O-substituované ketolidové deriváty erytromycinu